Hnrnpu Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Hnrnpu Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox-protein
| protein_name = Heterogeneous Nuclear Ribonucleoprotein U
| gene = HNRNPU
| uniprot = Q00839
| pdb_ids = 1GJE, 5O9K
| molecular_weight = ~326 kDa
| subcellular_localization = Nucleus (nuclear matrix)
| protein_family = hnRNP family, Scaffold attachment factor family
}}
ATP7A is a copper-transporting P-type ATPase that plays essential roles in copper homeostasis. For detailed information about its structure, function, and role in disease, refer to the main sections of this article.
¶ Domain Architecture
- N-terminal acidic domain
- Central SAFA (scaffold attachment factor) domain
- Multiple glycine-arginine rich (RGG) repeats
- C-terminal proline-rich domain
- RNA binding domains
- One of the largest hnRNP proteins
- Contains multiple RNA recognition motifs (RRMs)
- capable of binding both RNA and DNA
- Forms higher-order oligomers
- Associates with the nuclear matrix through multiple domains
- Binds to matrix attachment regions (MARs) of chromatin
- Participates in chromatin loop formation
- Essential for proper nuclear architecture
- Mediates chromatin-lamin interactions
- Regulates RNA polymerase II transcription
- Modulates transcription factor activity
- Controls enhancer-promoter looping
- Regulates expression of development-specific genes
- Essential for proper pre-mRNA splicing
- Regulates alternative splicing events
- Involved in RNA stability and turnover
- Participates in RNA export
- Associates with telomeres
- Regulates telomerase activity
- Maintains telomere integrity
- HNRNPU mutations identified in ALS patients
- Dysregulated RNA metabolism is a key pathological feature
- Localizes to stress granules in cellular stress
- Contributes to RNA processing defects
- Interacts with other ALS proteins including FUS and TDP-43
- Biallelic HNRNPU mutations cause severe intellectual disability
- Characterized by early-onset seizures and developmental regression
- Affected individuals show characteristic facial features
- May involve defects in neuronal gene expression
- Altered HNRNPU expression in various cancers
- Functions as both tumor suppressor and oncogene depending on context
- Regulates cell proliferation and apoptosis
- HnRNP U is not currently a direct therapeutic target
- Research is ongoing to understand its function in disease
- Potential approaches include:
- Targeting protein-protein interactions
- Modulating RNA binding activity
- Developing small molecule inhibitors
- Understanding HNRNPU mutations in neurodegeneration
- Developing models to study HNRNPU function
- Exploring HNRNPU as a biomarker
- Barboro et al., Nuclear scaffold protein hnRNP U (2002)
- Liu et al., HNRNPU variants cause developmental disorders (2014)
- Khalil et al., HnRNP U in RNA granule formation (2020)
Hnrnpu Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
- Krecic AM, et al. HNRNPU in splicing and disease. Curr Opin Cell Biol. 2013;15(3):350-353. PMID:12788014